Results for tag: "Cobicistat"

Cobicistat is a drug used to treat immune disorders, such as HIV and hepatitis C. It is a potent inhibitor of the cytochrome P450 3A4 enzyme, which is responsible for metabolizing many drugs. This makes it an effective booster for other drugs, allowing them to remain in the body longer and be more effective. It is also used to treat high blood pressure and can be used in combination with other drugs to treat HIV. Cobicistat is a relatively new drug, having been approved by the FDA in 2013. It is available in both oral and intravenous forms, and is generally well-tolerated. Common side effects include nausea, diarrhea, and headache. The Cobicistat market is growing rapidly, as it is increasingly being used to treat a variety of immune disorders. It is becoming increasingly popular due to its effectiveness and relatively low side effects. Companies in the Cobicistat market include Gilead Sciences, Merck, and Bristol-Myers Squibb. These companies are all major players in the pharmaceutical industry, and have been involved in the development and marketing of Cobicistat. Show Less Read more